Psoriasis-related systemic inflammation, originating in the skin microenvironment, contributes to comorbidities like cardiovascular disease, metabolic syndrome, psoriatic arthritis, and depression through shared TNF-α/IL-17 pathways that drive atherosclerosis, insulin resistance, and neuroinflammation (148–151). The gene discussed is IL17A; the disease is psoriasis.